Parents are showing remarkable courage in sharing their personal stories of loss in an attempt to convince the Albanese government to implement a pre-election commitment. A typo means the planned diabetes tender will proceed simultaneously with the recently announced parliamentary inquiry. How? Are 60-day dispensing and other changes going the same way as other recent reforms?
-
Latest News
New survey reveals most see living with COVID-19 as the 'new normal'
A new survey commissioned by Pfizer has found that Australians increasingly view the risk of COVID-19 as the ‘new normal’.
-
Podcast The 'Week in Review' Podcast - 9 June June 8, 2023
-
Latest News Industry leaders join Biointelect's new executive strategy panel June 9, 2023The company's new executive strategy panel includes experienced senior industry leaders Bruce Goodwin, Melissa McGregor and Cheryl Maley.
-
Latest News NZ patients welcome biosimilar but disappointed at failure to expand access June 9, 2023A leading New Zealand advocacy group has welcomed the reimbursement of a biosimilar of breast cancer therapy, trastuzumab, but expressed disappointment at the failure to use a lower price to widen access.
-
Latest News BMS welcomes 'One-Stop Shop' for clinical trials as an important step June 9, 2023Bristol Myers Squibb says the planned One-Stop Shop for clinical trials in Australia is an important step that needs to be supported with other reforms.
-
Latest News New report reveals 'crippling' impact of double dispensed quantities June 8, 2023A report from consulting firm RSM Australia has found that the speed and extent of the increase in maximum dispensed quantities will "cripple" community pharmacies.
-
Latest News Report confirms negative impact and highlights the risk of unintended consequences June 8, 2023Every community pharmacy will be impacted by the negative hit to dispensing remuneration. Yet not all can benefit from its reallocation to programs. This is partly because it is mostly a commitment to remunerate pharmacies for what they are already doing or to displace non-PBS revenue with official remuneration.
-
Latest News TGA approval for Janssen's CAR-T therapy for blood cancer June 8, 2023The TGA has approved Janssen's CAR-T therapy CARVYKTI (ciltacabtagene autoleucel) for blood cancer, and it will be considered again for funding in November.
-
Latest News England launches two-year pilot to fund access to weight loss medicine June 8, 2023UK Prime Minister Rishi Sunak has announced a £40 million two-year pilot under which it will fund weight loss therapies as part of a plan to cut hospital waiting lists.
-
Latest News MSD launches legal action against the US government over price negotiation power June 8, 2023MSD has launched legal action against the US government, arguing that its planned introduction of a medicine price negotiation power is unconstitutional.
-
Latest News Lack of consultation causing confusion and concern with just weeks until reform implementation June 7, 2023How can the existing arrangement be extended when the Commonwealth knows the unlicensed clinics are unlawfully dispensing PBS-listed medicines?
-
Latest News Sigma Healthcare wins Chemist Warehouse PBS supply contract June 6, 2023Sigma Healthcare has signed an agreement with Chemist Warehouse, under which it will supply PBS medicines and consumer goods for five years starting on 1 July 2024 and issue the pharmacy chain stock representing around 10.7 per cent of its value.
-
Latest News Protestors to march on NZ's 'beehive' in call for change on proposed law June 7, 2023A broad coalition of health stakeholders will march to New Zealand's parliament today in protest over proposed changes to the country's regulatory regime that directly impact patient access to medicines.
-
Latest News Vaxxas appoints former Pfizer executive as chief medical officer June 7, 2023Australian company Vaxxas, which is developing a novel vaccination platform technology, has appointed a former senior Pfizer executive as its chief medical officer.
-
Latest News Gilead launches new round of funding for Australian medical researchers June 7, 2023The Gilead Fellowship Grants Program is available for research in five key areas - HIV, chronic viral hepatitis, haematological oncology, solid tumours, and invasive fungal infections.
-
Latest News Minister working on 'transition arrangements' for private ODTP clinics June 6, 2023Health minister Mark Butler says he is working with states and territories on a transition plan for private clinics currently providing medicines for opiate dependence.
-
Latest News A third revision for scheduled National Diabetes Services Scheme tender June 6, 2023Embarrassment for officials with the health department changing the published date for its planned tender of the National Diabetes Services Scheme product schedule, including continuous glucose monitoring (CGM) products, following confusion at Budget Estimates late last week.
-
Australian Biotech Aravax launches new Phase 2 trial of peanut allergy candidate June 5, 2023Australian company Aravax has announced that the first patient has been dosed in its Phase 2 study (AVX-201) of investigative candidate PVX108 for the treatment of peanut allergy.
-
Australian Biotech ImmVirX raising $25 million to be led by healthcare VC OneVentures June 5, 2023Australian immunotherapy company ImmVirX has announced its plan to raise up to $25 million via Series B preference shares.
-
Latest News List of impacted medicines withheld until fifth and final meeting June 5, 2023Health department officials have revealed more information on the plan to increase the maximum dispensed quantities of 325 PBS-listed medicines, and much of it confirmed the complaints.
Australian Biotech
-
AVITA Medical announces US approval of RECELL for full thickness skin defects
June 8, 2023 -
Kinoxis Therapeutics secures US government grant to progress drug development
June 7, 2023 -
Neuren Pharmaceuticals receives milestone payment from US partner
June 7, 2023 -
Vaxxas appoints former Pfizer executive as chief medical officer
June 7, 2023 -
ImmVirX raising $25 million to be led by healthcare VC OneVentures
June 5, 2023
Other Health
-
Paralympians Curtis, Shae and Ben sign on as Bupa Ambassadors
June 7, 2023 -
Government delays the implementation of major medical device reform
June 7, 2023 -
Bupa announces health boost for The Big Issue vendors
June 5, 2023 -
Fifth Australian Healthcare Index reveals further decline in patient satisfaction
June 1, 2023 -
Latest report confirms ongoing impact of pandemic on hospitalisations
May 31, 2023
Latest Video
New Stories
-
New survey reveals most see living with COVID-19 as the 'new normal'
June 9, 2023 - - Latest News -
Industry leaders join Biointelect's new executive strategy panel
June 9, 2023 - - Latest News -
NZ patients welcome biosimilar but disappointed at failure to expand access
June 9, 2023 - - Latest News -
BMS welcomes 'One-Stop Shop' for clinical trials as an important step
June 9, 2023 - - Latest News -
The 'Week in Review' Podcast - 9 June
June 8, 2023 - - Podcast -
AVITA Medical announces US approval of RECELL for full thickness skin defects
June 8, 2023 - - Australian Biotech -
New report reveals 'crippling' impact of double dispensed quantities
June 8, 2023 - - Latest News